Real-World Analysis of Teclistamab Treatment for Relapsed Refractory Multiple Myeloma in Two Belgian University Hospitals

被引：0
作者：
Jadot, Gaspard [1 ]
Depaus, Julien [2 ]
Vekemans, Marie-Christiane [2 ,3 ]
机构：
[1] Clin Univ St Luc, Brussels, Belgium
[2] Univ Catholic Louvain, Dept Haematol, CHU UCL Namur, Yvoir, Belgium
[3] Univ Catholic Louvain, UCLouvain, Brussels, Belgium
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-032
引用
收藏
页码：S59 / S59
页数：1
相关论文
共 50 条
  • [31] Talquetamab plus Teclistamab in Relapsed or Refractory Multiple Myeloma
    Cohen, Yael C.
    Magen, Hila
    Gatt, Moshe
    Sebag, Michael
    Kim, Kihyun
    Min, Chang-Ki
    Ocio, Enrique M.
    Yoon, Sung-Soo
    Chu, Michael P.
    Rodriguez-Otero, Paula
    Avivi, Irit
    Quijano Carde, Natalia A.
    Kumar, Ashwini
    Krevvata, Maria
    Peterson, Michelle R.
    Di Scala, Lilla
    Scott, Emma
    Hilder, Brandi
    Vanak, Jill
    Banerjee, Arnob
    Oriol, Albert
    Morillo, Daniel
    Mateos, Maria-Victoria
    NEW ENGLAND JOURNAL OF MEDICINE, 2025, 392 (02) : 138 - 149
  • [32] Carfilzomib prescribing patterns and outcomes for relapsed or refractory multiple myeloma: a real-world analysis
    Dong, Sharlene
    Banerjee, Rahul
    Khan, Adeel M.
    Wang, Mengru
    Wang, Xiaoliang
    Afghahi, Anosheh
    Afrough, Aimaz
    Janakiram, Murali
    Wang, Bo
    Cowan, Andrew J.
    Sperling, Adam S.
    Anderson Jr, Larry D.
    Rajkumar, S. Vincent
    Kaur, Gurbakhash
    BLOOD CANCER JOURNAL, 2025, 15 (01):
  • [33] Teclistamab for relapsed refractory multiple myeloma patients on dialysis
    Lebreton, P.
    Lachenal, F.
    Bouillie, S.
    Pica, G. M.
    Aftisse, H.
    Pascal, L.
    Montes, L.
    Macro, M.
    Johnson, N.
    Harel, S.
    Fernandez, M.
    De Renzis, B.
    Lioure, B.
    Lazareth, A.
    Javelot, M.
    Louni, C.
    Huart, A.
    Perrot, A.
    BRITISH JOURNAL OF HAEMATOLOGY, 2024, 205 (05) : 2077 - 2079
  • [34] A glimpse into relapsed refractory multiple myeloma treatment in real-world practice in Spain: the GeminiS study
    Rios-Tamayo, Rafael
    Soler, Juan Alfons
    Garcia-Sanchez, Ricarda
    Persona, Ernesto Perez
    Arnao, Mario
    Garcia-Guinon, Antoni
    Domingo, Abel
    Gonzalez-Pardo, Miriam
    de la Rubia, Javier
    Mateos, Maria Victoria
    HEMATOLOGY, 2023, 28 (01)
  • [35] Current real-world treatment patterns and outcomes in patients with relapsed/refractory multiple myeloma.
    Willson, Jenny
    Bruno, Amanda
    Opalinska, Joanna
    Nelson, Jeanenne Joy
    Lunacsek, Orsolya
    Stafkey-Mailey, Dana
    Willey, Joanne P.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [36] Recent real-world treatment patterns and outcomes in US patients with relapsed/refractory multiple myeloma
    Bruno, Amanda S.
    Willson, Jenny L.
    Opalinska, Joanna M.
    Nelson, Jeanenne J.
    Lunacsek, Orsolya E.
    Stafkey-Mailey, Dana R.
    Willey, Joanne P.
    EXPERT REVIEW OF HEMATOLOGY, 2020, 13 (09) : 1017 - 1025
  • [37] Real-World Outcomes for the Treatment of Relapsed/Refractory Multiple Myeloma With Daratumumab: A Systematic Literature Review
    Gros Otero, B.
    Gungor, G.
    Gruppe, T. L.
    Wan, M.
    Jenkins, C.
    Helme, K.
    VALUE IN HEALTH, 2022, 25 (12) : S494 - S494
  • [38] Effectiveness and Safety of Teclistamab in Triple-Class Exposed Relapsed/Refractory Multiple Myeloma: Results of the French Real-World RetrosTECtive Study
    Perrot, Aurore
    Hulin, Cyrille
    Harel, Stephanie
    Manjrah, Hamza
    Leveque, Antoine
    Croizier, Carolyne
    Dony, Arthur
    Mohty, Mohamad
    Manier, Salomon
    Roussel, Murielle
    Orsini-Piocelle, Frederique
    Bauschert, Loic
    Coste, Arthur
    Frenzel, Laurent
    Vincent, Laure
    Breal, Claire
    Eveillard, Jean Richard
    Gerome, Thomas
    Tiab, Mourad
    Chalayer, Emilie
    Belkhir, Rakiba
    Mariette, Clara
    Moyer, Perrine
    Boumendil, Ariane
    Moreau, Philippe
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S78 - S79
  • [39] REAL-WORLD EXPERIENCE OF LENALIDOMIDE/DEXAMETHASONE TREATMENT FOR REFRACTORY/RELAPSED MULTIPLE MYELOMA (RRMM) PATIENTS
    Tognazzi, L.
    Rivolti, E.
    Quaresima, M.
    Labbozzetta, S.
    Gamberi, B.
    Merli, F.
    HAEMATOLOGICA, 2017, 102 : 137 - 137
  • [40] Carfilzomib Prescribing Patterns and Outcomes for Relapsed or Refractory Multiple Myeloma (RRMM): A Real-World Analysis
    Dong, Sharlene
    Banerjee, Rahul
    Khan, Adeel
    Wang, Mengru
    Wang, Xiaoliang
    Afghahi, Anosheh
    Afrough, Aimaz
    Janakiram, Murali
    Wang, Bo
    Cowan, Andrew
    Sperling, Adam
    Anderson, Larry
    Rajkumar, S. Vincent
    Kaur, Gurbakhash
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S258 - S259
12345